Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 3921
Journal of Community Medicine & Health Education peer review process verified at publons
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Genamics JournalSeek
- SafetyLit
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Hospital-acquired infections by carbapenem-resistant Gram-negative bacteria: An old hospital management challenge in a new technology era
Joint Event on Public Health, Womens Health, Nursing and Hospital Management
Catia Sofi a Gabriel Caneiras
University of Lisbon, Portugal
ScientificTracks Abstracts: J Community Med Health Educ
Abstract
The acquisition and emergence of carbapenem resistance among Gram-negative bacteria (GNB) is a major cause of concern, since carbapenems currently represent the treatment of choice for severe infections caused by multidrug-resistant (MDR) strains producing extended-spectrum β-lactamases (ESBL). In 2017, the World Health Organization had published a global priority pathogens list of antibiotic-resistant bacteria to help in prioritizing the research and development of new and effective antibiotic treatments. In this list, it identifi ed carbapenem-resistant Enterobacteriaceae (which includes Klebsiella pneumoniae and Escherichia coli), Pseudomonas aeruginosa and Acinetobacter baumannii, as the top three critical threats. Although great efforts have been made to enhance epidemiological surveillance in Europe, virulence traits and molecular characterization of carbapenem-resistant isolates from some countries remains scarce. Additionally, it remains somewhat unclear how pathogenic bacteria, its resistance and virulence, have evolved in over the time and its relationship with the healthcare system changes imposed by medical technologies. All combined, this thematic can constitute an important threat to safety patients, a signifi cative economic burden and a serious challenge to hospital management.Biography
Catia Sofi a Gabriel Caneiras has completed her graduation in Pharmaceutical Sciences (Pharm D) from University of Lisbon (Faculty of Pharmacy) and Master’s degree in Clinical Microbiology (MSc) in the Faculty of Medicine from the same university. Currently, she is a PhD student in the fi eld of Health Sciences and Technologies, specialty in Microbiology. She is working as the Healthcare Business Director and Scientifi c Director of Praxair Portugal and she is responsible for the telemedicine development area. She is a Senior Researcher in the Department of Microbiology and Immunology at FFUL and Invited Researcher at the Institute of Environmental Health. She has participated in more than 100 scientifi c activities, including 25 oral communications and 30 publications. She is an invited Reviewer of Journal of Medical Microbiology, Microorganisms, Journal of Clinical Medicine and International Journal of Environment and Public Health.
E-mail: ccaneiras@gmail.com
